Skip to main content
TipRanks
Go Ultimate75% OFF

MeVis Medical Solutions (0HI7) AI Stock Analysis

0 Followers
GB:0HI7

MeVis Medical Solutions

(LSE:0HI7)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Debt-free balance sheetZero total debt and stable equity materially reduce financial risk, preserve flexibility during weaker trading, and leave the company better positioned to fund operations or strategic investment without repayment or refinancing pressure.
Negative Factors
Multi-year revenue declineRevenue has declined for three consecutive annual reports, showing that the business has not recently converted its medical-imaging software position into sustained top-line expansion. Continued contraction could constrain operating leverage and reduce the resources available for growth initiatives.

MeVis Medical Solutions (0HI7) vs. iShares MSCI United Kingdom ETF (EWC)

-10%-5%0%5%10%15%20%25%30%GB:0HI7-6.41%EWC+21.04%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 36.40M
Dividend Yield
4.68%
Average Volume (3M)
1
Price to Earnings (P/E)
26.3
Beta (1Y)
-0.08
Revenue Growth
-6.92%
EPS Growth
-67.82%
Country
UK
Employees
127
Sector
Healthcare
Sector Strength
51
Industry
Software - Application

MeVis Medical Solutions Business Overview & Revenue Model

Company Description

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides...

MeVis Medical Solutions Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

GB:0HI7 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:SHLDE:SHL77OutperformEUR 49.04B22.2011.72%2.28%1.09%3.52%
DE:DRW8DE:DRW870OutperformEUR 1.82B12.3910.20%2.61%5.06%40.18%
DE:EUZDE:EUZ69NeutralEUR 959.88M23.2421.30%1.43%4.05%36.66%
DE:SBSDE:SBS54NeutralEUR 339.15M-697.50-18.69%2.15%――
DE:COPDE:COP53NeutralEUR 1.49B43.424.19%1.75%――
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%GB:0HI7DE:COPDE:DRW8DE:EUZDE:SBSDE:SHLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0HI7 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0HI7MeVis Medical Solutions22.00-1.51-6.41%
DE:COPCompuGroup Medical28.205.0221.64%
DE:DRW8Draegerwerk AG & Co. KGaA (0MT8)84.8025.6643.40%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik15.34-0.52-3.29%
DE:SBSSTRATEC Biomedical27.907.9439.78%
DE:SHLSiemens Healthineers43.953.157.72%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.